[Education of the autistic child].

P. Lenoir,C. Barthélémy

Soins Psychiatrie

Abstract:

What problem does this paper attempt to address?

Isolated Neurosarcoidosis Mimicking Multifocal Meningiomas: A Diagnosis Pitfall A Case Report

Kun Wang,Baying He,Wei Wang,Huanjiang Niu,Yirong Wang,Xiujun Cai,Shuxu Yang

DOI: https://doi.org/10.1097/md.0000000000004994

IF: 1.6

2016-01-01

Medicine

Abstract:Introduction: Neurosarcoidosis accounts for approximately 5% of the sarcoidosis, which develops exclusively in the nervous system and is always difficult to diagnose. We describe a rare case of isolated neurosarcoidosis mimicking as multifocal meningiomas. A 27-year-old male was admitted to our hospital with a history of unconsciousness and convulsion 1 month ago, which was suspected as a seizure. The results showed no abnormalities in complete blood count; serum electrolytes; erythrocyte sedimentation rate and ultrasonography of the liver, pancreas, spleen, kidney and parotid gland, and so on. Chest radiograph and electroencephalogram were also normal. Serum-angiotensin-converting enzyme slightly increased. Normal opening pressure was shown in cerebrospinal fluid sampling, which includes 8/mL white blood cells, 0.93 g/L protein, and 3.03mmol/L glucose. Enhanced magnetic resonance imaging revealed multifocal enhancement lesions, including left sphenoid wing region, left temporal and bilateral occipitoparietal region, which were suspected as multiple "meningioma". A left frontotemporal craniotomy was further performed. Both necrotizing and non-necrotizing granulomas were revealed in the pathological specimen, most of which were associated with multinucleated giant cells and macrophages. We could also see the fibrosis and inflammatory reaction in the sample composed of lymphocytes, histiocytes, and plasma cells. Histopathological examination showed that the cells were positive for human CD68 (KP1), CD68 (PGM1), and CD163; however, they were negative for the AF, epithelial membrane antigen, and glial fibrillary acidic protein. Tuberculosis-deoxyribonucleic acid test and special stains for acid-fast bacilli and fungi were negative. The diagnosis was finally made as isolated neurosarcoidosis. Then the patient was treated with additional corticosteroid therapy. Serial imaging examination 4 months later revealed that the lesions extremely decreased.Conclusion: The diagnosis of isolated central nervous system sarcoidosis was still difficult because of limitations of available diagnostic tests. So neurosarcoidosis in the clinical work should never be neglected.
[Future drug targets for Parkinson's disease].

E. Hirsch

DOI: https://doi.org/10.1016/S0001-4079(19)31718-2

2012-10-01

Abstract:
Benign Intracranial Hypertension: A Rare Manifestation of Neurosarcoidosis

Prashant Dubey,Satish Nirhale,Shalesh Rohatgi,Pranit Khandait

DOI: https://doi.org/10.7759/cureus.43363

2023-08-12

Cureus

Abstract:Sarcoidosis is an immune-mediated disease that can involve multiple systems. Sarcoidosis of the nervous system or neurosarcoidosis may present as cranial mononeuropathy, hypothalamic involvement, aseptic meningitis, granulomatous inflammation in the brain parenchyma or spinal cord, peripheral neuropathy, and, in rare cases, as myopathy and benign intracranial hypertension. The most common cranial nerve involvement is the facial nerve, which can present as unilateral or bilateral facial nerve palsy, often with recurrent episodes. Involvement of other cranial nerves such as the second and eighth cranial nerves has also been reported. Granulomatous inflammation in the spinal cord presents as myelopathy or radiculopathy. Peripheral neuropathy can manifest as mononeuropathy, mononeuritis multiplex, or generalized sensory-motor neuropathy. Carpal tunnel syndrome is more common in patients with sarcoidosis compared to the general population. Here, we describe the case of a 40-year-old female who presented with heaviness of the head and blurred vision, with a prior history of left-sided Bell's palsy. Bilateral papilledema was observed during the fundus examination. MRI of the brain revealed signs suggestive of benign intracranial hypertension. The cerebrospinal fluid (CSF) opening pressure was measured at 40 cmH2O. Biopsy of bilateral hilar lymphadenopathy indicated granulomatous inflammation consistent with sarcoidosis. The patient was started on steroids and acetazolamide, and she had a dramatic improvement in symptoms.
A Single Center Cross-Sectional Study of Clinical Outcomes

Rami Al-Hader,Justin Nofar,Ahmed Mohamedelkhair,Muhammad Affan,Lonni R. Schultz,Mirela Cerghet

DOI: https://doi.org/10.3390/jcm13175069

IF: 3.9

2024-08-29

Journal of Clinical Medicine

Abstract:Background/Objective: To describe the clinical features and radiological outcomes of patients with spinal cord neurosarcoidosis, treatments, and long-term follow-up for this rare disorder. Methods: A cross-sectional, retrospective medical chart review was performed for all patients with spinal cord neurosarcoidosis treated at a single center between 01/1995 and 12/2020. Radiological imaging, laboratory test results, the type of immunosuppressive therapy, and function test scores were reviewed. Results: We assessed 39 patients with spinal cord neurosarcoidosis (23 men, 16 women, mean age at presentation 46.4 years, SD 10.2 years). The mean (SD) duration of spinal cord neurosarcoidosis at data abstraction was 9.8 (6.3) years. There were 24 patients (62%) with extensive intramedullary lesions, 8 (21%) with multiple patchy intramedullary lesions, 12 (31%) with leptomeningeal involvement, and 7 (18%) with nerve root enhancement. The cervical spine was the most commonly affected region in 33 patients (85%). The most common presenting symptoms were paresthesia/neuropathic pain in 20 (51%) and weakness of extremities in 15 (38%) patients. Most patients (n = 37; 95%) had been treated with corticosteroids at symptom onset, and methotrexate was the most used immunosuppressive therapy (n = 19; 49%). Of 34 patients with follow-up magnetic resonance imaging (MRI) available, the median time to improvement per MRI was 10.8 months (95% CI, 6.1–17.0 months). Of 31 patients with MRI enhancement at presentation, 18 (58%) had complete enhancement resolution at follow-up, with a median time to resolution of 51.8 months (95% CI, 24.9–83.4 months). Patients had significantly lower pyramidal (p = 0.004) and sensory functional (p = 0.031) systems scores from presentation to the last clinic visit. Conclusions: Because spinal cord neurosarcoidosis is challenging to diagnose and no set treatment guidelines exist, clarifying patients' clinical parameters and responses to various treatments is needed to improve timely and efficient care. The incidence of spinal cord involvement in sarcoidosis in our cohort was higher than intracranial involvement and most patients had a long extensive intramedullary lesion. We also observed that most patients with spinal cord neurosarcoidosis improved clinically and radiologically after treatment; however, the resolution of MRI enhancement after immunosuppressive therapy may take years. Prospective studies of neurosarcoidosis will be crucial to address questions about effective treatment and long-term prognosis.

medicine, general & internal
[WOUNDS OF THE ABDOMINAL AORTA ( 2 CASES OPERATED ON AND RECOVERED)].

J. Cormier

Abstract:
Neurosarcoidosis manifesting as cavernous sinus syndrome in systemic sarcoidosis

Manxin Gao,Gi Tae Kwon,Mohammad Ruhul Amin

DOI: https://doi.org/10.1136/bcr-2024-259714

2024-07-16

Abstract:Neurosarcoidosis can manifest in various neurological presentations. The occurrence of cavernous sinus involvement in neurosarcoidosis is rare, which can complicate the diagnostic process. We present a case of neurosarcoidosis demonstrating progressively deteriorating right cavernous sinus syndrome in a woman in her 50s, affecting the oculomotor, abducens and the ophthalmic division of the trigeminal nerves. MRI demonstrated meningeal thickening along the lateral wall of the right cavernous sinus, and a pan-CT scan of the chest, abdomen and pelvis revealed disseminated sarcoidosis involving the lungs and the liver. Histopathological analysis of the liver lesion ultimately confirmed the diagnosis of sarcoidosis. This case underscores the significance of considering neurosarcoidosis as a potential cause of cavernous sinus syndrome. In such cases, early initiation of corticosteroid treatment, with or without steroid-sparing agents, is crucial to prevent disease progression and relapse.
Diagnostic challenges of neurosarcoidosis in non-endemic areas

Keshari Shrestha,B. K. Kleinschmidt-DeMasters,D. Ryan Ormond

DOI: https://doi.org/10.3389/fneur.2023.1220635

IF: 3.4

2024-01-12

Frontiers in Neurology

Abstract:Background: Neurosarcoidosis (NS) is a challenging diagnosis, particularly when cases occur in low-prevalence, non-endemic geographic regions. In the United States, the highest incidence is in the Midwest and Northeast, compared to our Southwest location. While it is well known that NS may clinically and neuroradiographically mimic meningeal carcinomatosis, autoimmune or infectious pachymeningitis, neurosyphilis, or tuberculosis, diagnosis may be particularly challenging if systemic signs of sarcoidosis are lacking or unconfirmed or if dural-based masses are present. We reviewed our Colorado experience with NS cases, focusing our study on cases where NS represented the first histological confirmation of disease. Methods: A search of departmental databases was conducted with the search term "neurosarcoidosis" to identify cases 1-2008 to 12-2019, inclusive of the given case numbers. Patients were only included if their clinical and neuroimaging features were unusual and only when a biopsy of the central nervous system (CNS) represented the first confirmed diagnosis of sarcoidosis. Results: A total of 17 cases were identified, of which the biopsy of the CNS was used for the initial confirmation of the disease in 9 of them. The most unusual findings were two patients with dural-based masses, one of which had pure NS as the cause of meningioma-like lesions and the second of which had coexistent meningioma and intimately admixed non-necrotizing granulomas of NS. Conclusion: NS with unusual features, especially in non-endemic areas, continues to yield diagnostic challenges for neurologists, neuroradiologists, and pathologists.

neurosciences,clinical neurology
Case report: Psychosis with catatonia in an adult man: a presentation of neurosarcoidosis

Griet Van Hoye,Barbara Willekens,Stephanie Vanden Bossche,Manuel Morrens,Filip Van Den Eede

DOI: https://doi.org/10.3389/fpsyt.2024.1276744

IF: 4.7

2024-03-05

Frontiers in Psychiatry

Abstract:Introduction: Sarcoidosis is a multisystem non-caseous granulomatous disease of unknown origin with predominant lung involvement and a variable clinical course. Although rare, neuropsychiatric manifestations such as confusion, problems in orientation, memory dysfunction, delusions, hallucinations and catatonia can be presenting features of sarcoidosis with nervous system involvement, also known as neurosarcoidosis. Case description: We present a 39-year-old man with acute-onset vertigo, balance problems and confusion quickly developing delusions, hallucinations, catatonic symptoms and suicidal behaviour. Symptoms appeared to be a manifestation of neurosarcoidosis. Diagnostic assessment: The differential diagnosis of psychosis is broad and should include pertinent auto-immune disorders, paraneoplastic, oncologic, metabolic, and neurodegenerative disorders. Basic systemic screening should include blood and urinary tests, a chest X-ray, brain CT scan and ECG. If neurosarcoidosis is suspected, an MRI of the brain with contrast and lumbar puncture are most appropriate. Multidisciplinary collaboration is essential to arrive at a correct diagnosis and effective management of the patient. Discussion: Despite the large number of sarcoidosis and psychosis studies, the etiology and pathogenesis of both illnesses remain incompletely understood. A common inflammatory etiopathological pathway has been postulated. Conclusions: Clinicians should consider organic causes when confronted with a middle-aged patient experiencing a first psychotic episode with an atypical onset, catatonic features, or dysfunction in orientation and/or memory, a complete lack of a positive familial psychiatric history and/or an atypical response to (psycho)pharmacological treatment.

psychiatry
Neurosarcoidosis Masquerading as Spinal Stenosis

Ameen Batheesh,Nina Borissovsky,Devy Zisman,Tal Gazitt

DOI: https://doi.org/10.3390/diagnostics14202296

IF: 3.6

2024-10-17

Diagnostics

Abstract:A 65-year-old woman was admitted to the neurology department with a suspected demyelinating disease due to complaints of progressive pain and weakness in both upper and lower limbs, as well as urinary incontinence. MRI of the spine revealed complex disc osteophyte with compression of the spinal cord in the cervical and lumbar spine at several vertebral levels, and localized enhancement in the cervical spine at the site of maximal spinal canal stenosis. During her hospitalization, the patient underwent extensive evaluation to rule out any systematic inflammatory diseases, infections, and malignancy. Chest CT revealed bilateral mediastinal lymphadenopathy. Transbronchial mediastinal lymph node biopsy showed numerous non-necrotizing granulomas without evidence of malignancy. After a thorough and careful exclusion of a demyelinating, infectious, and paraneoplastic myelopathies, and based on clinical, radiographic, and pathological findings, the patient was diagnosed with both neurosarcoidosis and spondylotic myelopathy. She was then treated for neurosarcoidosis, including glucocorticosteroids, azathioprine, and a biosimilar of the anti-TNF alpha agent infliximab, resulting in both clinical and radiographic improvement. Intramedullary spinal neurosarcoidosis is very rare and may present with clinical features of spondylotic myelopathy, with typical imaging findings occurring only in areas of spinal canal stenosis.

medicine, general & internal
Introduction: Strategies for developing genetically modified mice.

M. Hofker

DOI: https://doi.org/10.1007/978-1-60761-974-1_1

Abstract:
Eder‐Puestow Oesophageal Dilatation

W. McAdam,A. G. Morgan,A. Darnborough

DOI: https://doi.org/10.1002/BJS.1800671222

1980-12-01

Abstract:technique to our own data and whilst there can be few clinical situations in which this added information is likely to be of value, we note it with interest. We have looked at the transit times of "Tcm-HIDA in the liver and applied this to the assessment of the jaundiced patient. In our own experience the accumulation of IDA within the liver deteriorated as the serum bilirubin became elevated. The bilirubin was a better parameter of the ability of the liver to accumulate HlDA than either alanine aminotransferase or the alkaline hosphatase levels. We found that the images were difficuE to interpret for bilirubins of 100150 u/l and impossible for levels above this. We are currently assessing the relative efficacies of "Tc"'HIDA with "'Tcm p-Butyl IDA in hepatobiliary scanning. r. v. TAYLOR University Department of Clinical Surgery The Royal Infirmary Edinburgh EH3 9YW intrakepatic duct. We have not applied this subtraction
Central Nervous System Sarcoidosis: A National-Based registry study

Yazan Al-Zamer,Sami Al-Horani,Marah Akhdar,Ghaydah Majali,Hamza Alzghoul,Moustafa Younis,Pouya Ameli,Bashar Alzghoul

DOI: https://doi.org/10.36141/svdld.v41i3.15103

2024-09-24

Abstract:Background and aim: Sarcoidosis of the central nervous system (CNS) often presents deleterious effects on affected patients. Data and available literature discussing the diagnosis and treatment of this condition are scarce and inconsistent. In this study, we aim to shed light on demographics, management, diagnostics, and clinical complications of CNS sarcoidosis patients within the United States (US) based on a nation-wide registry questionnaire. Methods: Our retrospective study was conducted based on a national registry investigating 3,835 respondents to the Foundation for Sarcoidosis Research Sarcoidosis Advanced Registry for Cures Questionnaire (FSR-SARC). This national registry data was collected during the period of June 2014 to August 2019. We performed propensity score matching, summary, univariate, and multivariate analyses to establish a comparison between the presence and absence of central nervous system sarcoidosis. Results: We identified a total of 420/3634 (11.55%) patients having CNS sarcoidosis; 296 (70.5%) were females, 307 (73.1%) were Caucasian and 81 (19.3%) were African American. The mean (±SD) age at diagnosis of CNS sarcoidosis was 43.3 (±12) years old. Multiorgan involvement (≥3 organs) was present in 318/420 (75.7%) patients. Brain magnetic resonance imaging was the most common ancillary diagnostic modality used and reported to be abnormal 251/328 (76.5%). Corticosteroids were the most used treatment by CNS sarcoidosis patients 206/420 (49.0%) followed by cytotoxic agents 180/420 (42.9%). Conclusions: CNS sarcoidosis prevalence in our cohort was similar to what has been described previously. The most prevalent imaging modality used was cranial MRI. Corticosteroids were the most used medications. Lastly, CNS sarcoidosis showed a propensity to cause several clinical complications such as chronic pain syndrome and disability.
Neurosarcoidosis as a rapidly progressive dementia associated with normal pressure hydrocephalus

Fernando Jabif,Máximo Rousseau-Portalis,Claudia Burbano,Diego Andresik,Bernardo Martínez

Abstract:Neurosarcoidosis (NS) is a rare subtype of sarcoidosis with a poor prognosis and diverse clinical presentations that often poses a diagnostic and therapeutic challenge. We describe the case of a 53-year-old male with an initial diagnosis of lingual sarcoidosis, who subsequently developed ataxia and rapidly progressive cognitive impairment. A lumbar puncture revealed hypoglycorrhachia, hyperproteinorrachia, lymphocytic pleocytosis, and elevated IL-6 levels (600 pg/ml). Cerebrospinal fluid flow cytometry showed an elevated CD4 lymphocyte concentration and a CD4+/CD8+ ratio of 3.91, indicative of NS. Brain MRI showed hyperintense periventricular and subcortical lesions on FLAIR/T2 resembling progressive multifocal leukoencephalopathy (PML), although negative PCR for JC virus ruled out the differential diagnosis. Following a favorable evolutionary course with corticosteroid pulses, the patient relapsed with normotensive hydrocephalus, treated with immunosuppressants and ventriculoperitoneal shunting with a good response to date. This case underscores the importance of maintaining a high index of suspicion for NS in individuals with sarcoidosis and neurologic symptoms. In these cases, cerebrospinal fluid biomarkers such as IL-6 and CD4+/CD8+ ratio are essential to guide the diagnosis. Furthermore, it highlights that hydrocephalus is a rare complication and requires a multidisciplinary approach, including medical and neurosurgical treatment.
Advice about Life Plans from Mothers, Fathers, and Siblings in Always-Married and Divorced Families during Late Adolescence

C. Tucker,B. Barber,J. Eccles

DOI: https://doi.org/10.1023/A:1012233712862

2001-12-01

Abstract:
Neurosarcoidosis complicated by systemic vasculitis

Alexander Carvajal-González,Octavio Arevalo-Espejo,Maria Carolina Beeter,Sarwat Umer,Oleg Chernyshev

DOI: https://doi.org/10.1016/j.amjms.2024.09.008

2024-09-24

Abstract:A 62-year-old woman with medical history of hypertension, diabetes mellitus, coronaropathy, neurosarcoidosis, s/p craniotomy (brain mass resection) presented with worsening headaches, generalized weakness, vomiting, and hyporexia over two weeks. Brain MRI showed worsening of the known right cavernous sinus mass, vasculitis panel was negative. Patient received IV steroids; during hospitalization, she had a syncopal episode, CT Head was normal, EKG showed new T-wave inversion with troponin elevation. She experienced worsening mentation, left-sided hemiparesis; CT head showed acute hypodensity in the right MCA territory, CTA revealed bilateral distal M1 segment stenosis. Ineligible for thrombolysis/thrombectomy, she was started on aspirin. Echocardiograms were normal. Ischemic signs in her right toes prompted an aortogram showing arterial obstructions in the RLE, necessitating SFA stent placement, and clopidogrel. IV cyclophosphamide was added without additional vascular complications. This case illustrates neurosarcoidosis complicated by systemic vasculitis of medium-large vessels, responding to aggressive immunosuppression with glucocorticoids and cytotoxic agents.
P-THER-14: A new, simple training model for endoscopic ultrasound-guided transmural pancreatic pseudocysts and fluid collections drainage

Ratchamon Pinyoteppratarn,Kannikar Laohavichit,T. Ratanachu-ek,Jerasak Wannaprasert,T. Chantarojanasiri,Aroon Siripun,Jirat Jiratham-opas,Kaetsaraporn Chaichana

DOI: https://doi.org/10.4103/2303-9027.212339

2017-08-01

Endoscopic Ultrasound

Abstract:Background and Objectives: Endoscopic ultrasound (EUS)-guided drainage of pancreatic pseudocysts and fluid collections is an important therapeutic procedure. However, this procedure can be technically challenging especially for inexperienced (beginner endosonographer) and requiring a learning curve to obtain good results. Currently, several training models for EUS-guided drainage of pancreatic pseudocysts have been developed, but each has its own merits and limitations. Materials and Methods: The authors have created a gelatin model that is easy and inexpensive to prepare. The materials for preparation are gelatin and corn starch. It is applicable for multiple usage during training in punctures, aspirations, stents placement, and removal technique. It can be cauterized, dilated, and applicable for stent placement. Results: The total cost for one unit model was 10 USD. A single model can be applied at least four punctures with sustainable good quality. Preliminary surveys obtained from users demonstrated good ratings such as target lesion can be identified clearly, and needle puncture, dilate, and stenting can be performed with realistic resistance feeling. The echogenicity and ultrasonography imaging were comparable to human visceral organs. In addition, there was no need to concern about hazard control and dangers from animal-related disease. Conclusion: A new gelatin training model for EUS-guided pancreatic pseudocyst drainage is cost-effective, feasible, realistic, and safe.
Systemic and Neurosarcoidosis With Rare Involvement of the Extremities' Peripheral Nerves

Fathima Fijula Palot Manzil,Joshua Eichhorn,Harleen Kaur

DOI: https://doi.org/10.1097/rlu.0000000000005176

IF: 10.6

2024-05-05

Clinical Nuclear Medicine

Abstract:We present a case of sarcoidosis with a rare presentation of involvement of peripheral nerves of the lower limbs and subcutaneous nodules detected on 18F-FDG PET/CT. The patient also had involvement of the spinal nerves and dura, histologically proven to be sarcoidosis. There were other manifestations of systemic sarcoidosis like metabolically active cervical and mediastinal lymphadenopathy. This case highlights the role of 18F-FDG PET/CT in evaluating the uncommon sites of sarcoid involvement. Although many cases of sarcoid involvement of central nervous system have been reported, peripheral nerves involvement in the extremities was not found on a literature search.

radiology, nuclear medicine & medical imaging
Treatment of recalcitrant erythrodermic psoriasis with ustekinumab

G. Stinco,A. Piccirillo,E. Errichetti,S. Bergamo,P. Patrone

DOI: https://doi.org/10.1684/ejd.2014.2325

2014-05-01

Abstract:Erythrodermic psoriasis (EP) can be challenging to treat since several factors, such as failure or intolerance, limit favourable outcomes with traditional therapies [1]. The conventional treatments recommended for EP are methotrexate, oral retinoids and cyclosporine [2], although systemic steroids are still used, especially in severe and unstable forms, since they usually induce a rapid clinical improvement [2, 3]. Recently, some cases of EP have been successfully treated with biological agents, [...]
Pearls & Oy-sters: Vocal Cord Palsy as the Presenting Manifestation of Neurosarcoidosis

Shruti Iyer,Thanmayi Palegar,Ajitesh Ojha

DOI: https://doi.org/10.1212/WNL.0000000000209955

IF: 9.9

2024-11-12

Neurology

Abstract:Neurosarcoidosis poses a significant diagnostic challenge due to the diversity of presenting symptoms. We report a case of a 64-year-old woman with a history of hypertension and diabetes who presented with 3 weeks of progressive dysphonia and dysphagia. Initial differential diagnosis included myasthenia gravis, Guillain-Barré syndrome, infections such as syphilis or HIV, and neurosarcoidosis. Laryngoscopy and EMG demonstrated cranial nerve X and XII palsy. MRI brain was unrevealing, but a CT of the head and neck showed radiologic evidence of left vocal cord paralysis and asymmetric prominence of the left lingual tonsillar tissue. Her clinical findings, elevated CSF-ACE (angiotensin-converting enzyme) and CSF sIL-2R (soluble interleukin-2 receptor), and a previous thoracic tissue biopsy showing granulomas led to a 'probable' diagnosis of neurosarcoidosis after the thorough exclusion of other diagnoses. The patient was treated with pulse steroids and outpatient initiation of infliximab. There was prompt improvement in dysphagia and gradual amelioration of dysarthria and dysphonia. This case illustrates cranial nerve X and XII palsy as the presentation of neurosarcoidosis. In addition, it demonstrates the value of CSF sIL-2R as a biomarker for neurosarcoidosis and highlights the growing popularity of using steroid-sparing agents for treatment to achieve better outcomes with fewer side effects.
Neurosarcoidosis-Induced Winging Scapula: Efficacy of Infliximab Treatment in Addressing Multifaceted Challenges

Richa Purohit,Ravi Shahu Khal,Kathleen McCabe,Neha Bhanusali,Maria Farooq,Shazia Beg

DOI: https://doi.org/10.1093/mrcr/rxae030

2024-05-23

Abstract:Sarcoidosis, a systemic granulomatous disease primarily affecting the respiratory and lymphatic systems, can rarely manifest as neurosarcoidosis either in isolation or alongside other systemic symptoms. Here, we describe the case of a 45-year-old male with a history of recurrent sinusitis refractory to antibiotics, who presented to the emergency department with sinus congestion and dysphagia. Clinical examination revealed left lower motor neuron facial palsy and enlarged submandibular salivary glands. Despite obtaining negative results from various antibody panels, the patient exhibited elevated Angiotensin Converting Enzyme levels of 83 nmol/kg/min. Additionally, computed tomography chest scans revealed bilateral hilar and mediastinal lymph node enlargement, findings consistent with sarcoidosis. Otorhinolaryngology evaluation for dysphagia confirmed left vocal cord palsy. Following a negative infectious disease workup, submandibular salivary gland biopsy confirmed sarcoidosis. Treatment with mycophenolate mofetil and oral steroids led to gradual improvement in salivary gland swelling, dysphagia, and facial palsy. However, worsening left shoulder pain prompted further investigation, revealing winging of the left scapula on repeat examination. Magnetic resonance imaging (MRI) of the cervical spine revealed a six mm hyperintensity in the left dorsal cord at the C5 level, suggesting possible neurosarcoidosis vs. demyelinating disease. Subsequently, the patient was prescribed anti-tumor necrosis factor alpha inhibitor infliximab. Subsequent MRI of the cervical spine, conducted six months after initiating Infliximab therapy, indicated resolution of the lesions. This positive outcome was supported by the patient's report of symptom improvement, notably reduced shoulder pain and improvement in left scapular winging. This case underscores the unusual co-occurrence of Bell's palsy and vocal cord palsy in the same patient, along with the potential contribution of neurosarcoidosis to the winged scapula. Additionally, it sheds light on the positive response of neurosarcoidosis to Infliximab therapy.

[Education of the autistic child].

Isolated Neurosarcoidosis Mimicking Multifocal Meningiomas: A Diagnosis Pitfall A Case Report

[Future drug targets for Parkinson's disease].

Benign Intracranial Hypertension: A Rare Manifestation of Neurosarcoidosis

A Single Center Cross-Sectional Study of Clinical Outcomes

[WOUNDS OF THE ABDOMINAL AORTA ( 2 CASES OPERATED ON AND RECOVERED)].

Neurosarcoidosis manifesting as cavernous sinus syndrome in systemic sarcoidosis

Diagnostic challenges of neurosarcoidosis in non-endemic areas

Case report: Psychosis with catatonia in an adult man: a presentation of neurosarcoidosis

Neurosarcoidosis Masquerading as Spinal Stenosis

Introduction: Strategies for developing genetically modified mice.

Eder‐Puestow Oesophageal Dilatation

Central Nervous System Sarcoidosis: A National-Based registry study

Neurosarcoidosis as a rapidly progressive dementia associated with normal pressure hydrocephalus

Advice about Life Plans from Mothers, Fathers, and Siblings in Always-Married and Divorced Families during Late Adolescence

Neurosarcoidosis complicated by systemic vasculitis

P-THER-14: A new, simple training model for endoscopic ultrasound-guided transmural pancreatic pseudocysts and fluid collections drainage

Systemic and Neurosarcoidosis With Rare Involvement of the Extremities' Peripheral Nerves

Treatment of recalcitrant erythrodermic psoriasis with ustekinumab

Pearls & Oy-sters: Vocal Cord Palsy as the Presenting Manifestation of Neurosarcoidosis

Neurosarcoidosis-Induced Winging Scapula: Efficacy of Infliximab Treatment in Addressing Multifaceted Challenges